Home Investors Financial Filings ... Annual report which provides a comprehensive overview of the company for the past year ... 1-25 26-45. Ampio Pharmaceuticals, ...
Investor Relations ; Ameriprise Clients · Contact Ameriprise. 1.800.862.7919 ; Investor Relations · Investor.Relations@ampf.com ; Transfer Agent · shareholder@ ...
Get the latest insights on Ampio Pharmaceuticals, Inc. (AMPE) with press releases and corporate news to help you in your trading and investing decisions.
A development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions ...
Ameriprise Financial, Inc. (NYSE:AMP) is hosting its first Financial Community Presentation on Wednesday, November 15, 2006 at 1:30 p.m. (ET). At the ...
Missing: ampe | Show results with:ampe
Welcome to American Municipal Power, Inc.'s (AMP) investor relations page. Investment in bonds issued by AMP allows for beneficial investment in generation and ...
Missing: ampe | Show results with:ampe
Find the latest SEC Filings data for Ampio Pharmaceuticals, Inc. (AMPE) including 10-K and 10-Q forms at Nasdaq.com.
. . Company Contact. . Investor Relations. Joe Hassett. joeh@gregoryfca.com. 484-686-6600. . Media Contact. Katie Kennedy. katie@gregoryfca.com. 610-731- ...
Find the latest Ampio Pharmaceuticals, Inc. (AMPE) stock quote, history, news and other vital information to help you with your stock trading and investing.
Missing: relations | Show results with:relations
Introduction Our History Investor Factsheet Join Mailing List Our Locations Financial Calendar ... Financial Report · Earnings Release · Earnings ... AMP Q4/FY 2023 ...